DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,189,000 | +126.5% | 58,993 | +319.3% | 0.02% | +150.0% |
| Q2 2021 | $525,000 | -34.0% | 14,070 | -54.8% | 0.01% | -40.0% |
| Q1 2021 | $796,000 | -23.5% | 31,145 | -34.0% | 0.01% | -28.6% |
| Q4 2020 | $1,040,000 | +295.4% | 47,225 | +355.8% | 0.01% | +180.0% |
| Q2 2020 | $263,000 | +281.2% | 10,361 | +177.8% | 0.01% | +150.0% |
| Q1 2020 | $69,000 | -97.0% | 3,729 | -96.4% | 0.00% | -95.2% |
| Q4 2019 | $2,304,000 | +418.9% | 104,577 | +271.4% | 0.04% | +425.0% |
| Q2 2019 | $444,000 | +15.3% | 28,161 | +7.1% | 0.01% | -33.3% |
| Q1 2019 | $385,000 | +193.9% | 26,290 | +115.1% | 0.01% | +100.0% |
| Q4 2018 | $131,000 | -26.8% | 12,222 | +4.2% | 0.01% | -40.0% |
| Q3 2018 | $179,000 | +75.5% | 11,733 | +10.0% | 0.01% | +66.7% |
| Q1 2018 | $102,000 | – | 10,665 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |